Phospholipase A₂ activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease

Author： Schaeffer Evelin Forlenza Orestes Gattaz Wagner

ISSN： 0033-3158

Source： Psychopharmacology, Vol.202, Iss.1-3, 2009-01, pp. : 37-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment of Alzheimer's Disease: Classical Therapeutic Approach

Current Pharmaceutical Analysis, Vol. 12, Iss. 2, 2016-05 ,pp. : 82-90

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic therapy for early-stage HER2-positive breast cancers: Time for a less-is-more approach?

By Paplomata Elisavet Nahta Rita O'Regan Ruth M.

Cancer, Vol. 121, Iss. 4, 2015-02 ,pp. : 517-526

Blackwell Publishing

Access to resources Recommend Favorite

Intranasal insulin improves cognitive function in patients with early Alzheimer's disease

Inpharma, Vol. 1, Iss. 1628, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Non-Classical Therapeutic Approach in the Treatment of Alzheimers Disease: A Mini Review

Letters in Drug Design & Discovery, Vol. 12, Iss. 2, 2015-02 ,pp. : 158-164

Bentham Science Publishers

Access to resources Recommend Favorite